Granulocyte-colony stimulating factor (G-CSF) producing malignant pleural mesothelioma: Report of a case

Thoracic Cancer 2015 January [Link] Fujiwara A, Higashiyama M, Kanou T, Okami J, Tokunaga T, Tomita Y, Kodama K. Abstract This report presents a case of malignant pleural mesothelioma (MPM) producing granulocyte colony-stimulating factor (G-CSF) that was treated by tumor resection. A 76-year-old male presented with a huge right-side chest wall tumor, along with a…

Read More

An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma

Journal of Clinical Pathology 2015 August 17 [Epub ahead of print] [Link] Klebe S, Swalling A, Jonavicius L, Henderson DW. Abstract Immunohistochemical detection of thyroid transcription factor-1 (TTF-1) plays an important role in the diagnosis and subclassification of non-small cell carcinomas of the lung in biopsy and some cytology samples, specifically for identification of squamous…

Read More

Increased Standardised Incidence Ratio of Malignant Pleural Mesothelioma in Taiwanese Asbestos Workers: A 29-Year Retrospective Cohort Study

BioMed Research International 2015 [Link] Lin CK, Chang YY, Wang JD, Lee LJ. Abstract Objective This paper aimed to determine the standardised incidence ratio (SIR) of malignant pleural mesothelioma (MPM) in workers exposed to asbestos in Taiwan. Methods All workers employed in asbestos-related factories and registered by the Bureau of Labour Insurance between 1 March,…

Read More

Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo

Respirology 2015 August 5 [Epub ahead of print] [Link] Vazakidou ME, Magkouta S, Moschos C, Psallidas I, Pappas A, Psarra K, Kalomenidis I. Abstract Background and Objective The mechanistic target of rapamycin (mTOR) promotes cancer cell proliferation and survival, transduces pro-angiogenic signals and regulates immune cell differentiation and function. We hypothesized that temsirolimus, an mTOR…

Read More

Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level

Journal of Human Genetics 2015 August 6 [Epub ahead of print] [Link] Emi M, Yoshikawa Y, Sato C, Sato A, Sato H, Kato T, Tsujimura T, Hasegawa S, Nakano T, Hashimoto-Tamaoki T. Abstract Malignant mesothelioma (MM) is an asbestos-related malignancy arising from surface serosal cells of pleural and peritoneal cavities. Somatic mutations of BRCA1 associated…

Read More

Ectopic ACTH secretion (EAS) associated to a well-differentiated peritoneal mesothelioma: case report

BMS Endocrine Disorders 2015 August 8 [Link] Mendoza CF, Ontiveros P, Xibillé DX, Rivera MH. Abstract Background The association between mesotheliomas and ectopic ACTH secretion has been rarely reported; we present the first case of ectopic ACTH secretion (EAS) associated with a well-differentiated peritoneal mesothelioma in whom the high dose dexamethasone suppression test (HDDST) results…

Read More

Functional Alteration of Natural Killer Cells and Cytotoxic T Lymphocytes upon Asbestos Exposure and in Malignant Mesothelioma Patients

BioMed Research International 2015 [Link] Nishimura Y, Kumagai-Takei N, Matsuzaki H, Lee S, Maeda M, Kishimoto T, Fukuoka K, Nakano T, Otsuki T. Abstract Malignant mesothelioma is caused by exposure to asbestos, which is known to have carcinogenic effects. However, the development of mesothelioma takes a long period and results from a low or intermediate…

Read More